Our findings help researchers to deeply understand the pathological molecular mechanisms of HCC at the transcriptional regulation level, identify TF-related prognostic biomarkers for HCC, and provide important clues for exploring TFs as drug targets in HCC. The gene discussed is TF; the disease is hepatocellular carcinoma.